Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.2 is now displayed on the page, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded Schizophrenia as a condition and related topics: MedlinePlus Genetics to the study page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe Conditions section no longer lists Schizophrenia or the related MedlinePlus Genetics topic.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check41 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now includes topic tags for Schizophrenia and related resources (MedlinePlus Genetics) and shows a Revision: v3.4.2. The prior funding notice about government operating status and the earlier Revision: v3.4.1 have been removed.SummaryDifference0.4%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.